| Authors: |
Al-Sawaf O; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Fürstenau M; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Giza A; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., von Tresckow J; Department of Hematology, Oncology and Palliative Care, Katholisches Klinikum Bochum, Ruhr University Bochum, Bochum, Germany., Fink AM; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Simon F; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Tausch E; Division of Chronic Lymphocytic Leukaemia, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of Chronic Lymphocytic Leukaemia, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Sivcheva L; First Department of Internal Medicine, Hristo Botev Multiprofile Hospital for Active Treatment, Vratsa, Bulgaria., Schwarer A; Department of Haematology, Box Hill Hospital, Melbourne, Australia., Loscertales J; Hematology Department, Hospital De La Princesa, Madrid, Spain., Weinkove R; Te Rerenga Ora Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Wellington, New Zealand.; Cancer Immunotherapy Program, Malaghan Institute of Medical Research, Wellington, New Zealand., Strumberg D; Medical Department III, Hematology/Oncology, Marien Hospital Herne, University Hospitals of the Ruhr University Bochum, Bochum, Germany., Kilfoyle A; Haematology Department, Palmerston North Hospital, Palmerston North, New Zealand., Juliusson G; Department of Haematology, Lund University Cancer Center, Lund, Sweden., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Illmer T; Praxis of Haematology and Oncology, Dresden, Germany., Gregor M; Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland., Thornton P; Department of Haematology, Beaumont Hospital, Dublin, Ireland., Janssens A; Department of Oncology, University Hospitals Leuven, Leuven, Belgium., Tadmor T; Deoartment of Hematology, Bnai-Zion Medical Center, Haifa, Israel., Lindström V; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Staber P; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Wendtner CM; Department of Medicine III and Comprehensive Cancer Center (Munich), Ludwig-Maximilians University Hospital, Ludwig Maximilian University, Munich, Germany., Kreuzer KA; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Ritgen M; Department II of Internal Medicine, University of Schleswig-Holstein, Kiel, Germany., Stilgenbauer S; Division of Chronic Lymphocytic Leukaemia, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Kater AP; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Niemann C; Department of Hematology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Fischer K; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Eichhorst B; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Hallek M; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. |
